Neuroinflammation in schizophrenia-related psychosis: A PET study

Journal of Nuclear Medicine

Volumn 50, Issue 11, 2009, Pages 1801-1807

  Doorduin, Janine ^a   De Vries, Erik F J ^a   Willemsen, Antoon T M ^a   De Groot, Jan Cees ^a   Dierckx, Rudi A ^a   Klein, Hans C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

11C PK11195; Microglia; Neuroinflammation; PET; Psychosis; Schizophrenia

Indexed keywords

HALOPERIDOL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; OLANZAPINE; RISPERIDONE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; ENCEPHALITIS; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; MALE; MICROGLIA; NEGATIVE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITIVE SYNDROME; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM;

ADULT; AMIDES; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; ISOQUINOLINES; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; SCHIZOPHRENIA; YOUNG ADULT;

EID: 70350724581     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.066647     Document Type: Article

References (37)

1. Muller N, Schwarz MJ. A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Eur Arch Psychiatry Clin Neurosci. 2008;258:97-106. (Pubitemid 351758763)
2. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314-1318. (Pubitemid 40746128)
3. Doorduin J, de Vries EFJ, Dierckx RA, Klein HC. PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders. Curr Pharm Des. 2008;14:3297-3315.
4. Bayer TA, Buslei R, Havas L, Falkai P. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci Lett. 1999;271:126-128. (Pubitemid 29400683)
5. Radewicz K, Garey LJ, Gentleman SM, Reynolds R. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J Neuropathol Exp Neurol. 2000;59:137-150. (Pubitemid 30106470)
6. Steiner J,Mawrin C, Ziegeler A, et al. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol. 2006;112: 305-316. (Pubitemid 44275885)
7. Wierzba-Bobrowicz T, Lewandowska E, Lechowicz W, Stepien T, Pasennik E. Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. Folia Neuropathol. 2005;43:81-89. (Pubitemid 40975402)
8. 11C]PK11195 positron emission tomography study. Biol Psychiatry. 2008;64:820-822.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994.
10. Arnold SE, Trojanowski JQ, Gur RE, Blackwell P, Han LY, Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen Psychiatry. 1998;55:225-232. (Pubitemid 28113906)
11. Falke E, Han LY, Arnold SE. Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia. Psychiatry Res. 2000;93:103-110. (Pubitemid 30139477)
12. Kurumaji A, Wakai T, Toru M. Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics. J Neural Transm. 1997;104:1361-1370. (Pubitemid 28031830)
13. Steiner J, Bielau H, Brisch R, et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res. 2008;42:151-157. (Pubitemid 350061255)
14. Chavarria A, Alcocer-Varela J. Is damage in central nervous system due to inflammation? Autoimmun Rev. 2004;3:251-260.
15. Chen MK, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008;118:1-17.
16. Itzhak Y, Baker L, Norenberg MD. Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: evidence for multiplicity. Glia. 1993;9:211-218.
17. Raghavendra Rao VL, Dogan A, Bowen KK, Dempsey RJ. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp Neurol. 2000;161:102-114. (Pubitemid 30136533)
18. Banati RB, Myers R, Kreutzberg GW. PK ('peripheral benzodiazepine')- binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J Neurocytol. 1997;26: 77-82. (Pubitemid 27242473)
19. Kuhlmann AC, Guilarte TR. Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem. 2000; 74:1694-1704.
20. Steiner J, Bielau H, Bernstein HG, Bogerts B, Wunderlich MT. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J Neurol Neurosurg Psychiatry. 2006;77:1284-1287. (Pubitemid 44654765)
21. Rothermundt M, Peters M, Prehn JH, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech. 2003;60:614-632.
22. Itzhak Y, Norenberg MD. Regulation of peripheral-type benzodiazepine receptors in cultured astrocytes by monoamine and amino acid neurotransmitters. Brain Res. 1994;660:346-348. (Pubitemid 24303640)
23. Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361:281-288. (Pubitemid 36126187)
24. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry. 2000;157:16-25. (Pubitemid 30027416)
25. Heckers S, Heinsen H, Geiger B, Beckmann H. Hippocampal neuron number in schizophrenia: a stereological study. Arch Gen Psychiatry. 1991;48:1002-1008.
26. Walker MA, Highley JR, Esiri MM, et al. Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia. Am J Psychiatry. 2002;159:821-828.
27. Harrison PJ. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl). 2004;174:151-162.
28. Muller N, Riedel M, Scheppach C, et al. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry. 2002;159:1029-1034. (Pubitemid 34586950)
29. Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B. Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophr Res. 2007;90:179-185. (Pubitemid 46177578)
30. Miyaoka T, Yasukawa R, Yasuda H, Hayashida M, Inagaki T, Horiguchi J. Minocycline as adjunctive therapy for schizophrenia: an open-label study. Clin Neuropharmacol. 2008;31:287-292.
31. Levkovitz Y, Mendlovic S, Issaki S, Braw Y, Levkovitch-Verbin H, Gal G. Minocycline ameliorates negative symptoms and cognitive deficits in early-phase schizophrenia: a double-blind, randomized placebo-controlled study. Schizophr Res. 2008;98(suppl 1):14.
32. Laan W. Anti-Inflammatory Drugs and Psychosis [thesis]. University of Utrecht, Utrecht, The Netherlands; 2008.
33. Kato T, Monji A, Hashioka S, Kanba S. Risperidone significantly inhibits interferon-γ-induced microglial activation in vitro. Schizophr Res. 2007;92: 108-115. (Pubitemid 46561234)
34. Hou Y, Wu CF, Yang JY, et al. Effects of clozapine, olanzapine and haloperidol on nitric oxide production by lipopolysaccharide-activated N9 cells. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1523-1528. (Pubitemid 44634941)
35. Papadopoulos V, Lecanu L. Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma. Exp Neurol. 2009;219:53-57.
36. Wilms H, Claasen J, Rohl C, Sievers J, Deuschl G, Lucius R. Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro. Neurobiol Dis. 2003;14:417-424. (Pubitemid 37543520)
37. Sarnowska A, Beresewicz M, Zablocka B, Domanska-Janik K. Diazepam neuroprotection in excitotoxic and oxidative stress involves a mitochondrial mechanism additional to the GABAAR and hypothermic effects. Neurochem Int. 2009;55:164-173.